PCM - Pharma Consulting & Management GmbH > In-/Out-Licensing > Ethical > Propofol EDTA - available for licensing

Ethical pharmaceuticals

Propofol EDTA

Short-acting general anaesthtic based long-chain triglycerides.


Induction and maintenance of general anaesthesia.

Pharmaceutical form and presentations

Solution for intravenous application.

10 mg/ml, 20 ml ampoule,

10 mg/ml, 50 ml vial.


By intravenous bolus injection or continuous intravenous infusion.

Special feature

Propofol EDTA contains disodium edetate to retard the rate of growth of microorganisms.

Produced in

European Union

Available countries

On request.


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.